Login Register Cart 0
Generic placeholder image

Micro and Nanosystems

Editor-in-Chief

ISSN (Print): 1876-4029
ISSN (Online): 1876-4037

Back
Journal Home About Journal Editorial Board Journal Insight Current Issue Volumes/Issues
Subscribe
Research Article

Development and In vitro Assessment of Topical Microemulsion Based Pluronic-Lecithin Organogel for the Management of Arthritic Pain

Author(s): Abhishek Yadav, Vikas Jhawat*, Rahul Pratap Singh, Sunita Chauhan, Rohit Dutt, Rajesh Goyal and Deependra Singh

Volume 16, Issue 1, 2024

Published on: 12 February, 2024

Page: [36 - 45] Pages: 10

DOI: 10.2174/0118764029280588231215044630

Price: $65

Abstract

Background: Topical delivery of NSAIDs through organogels might transport lornoxicam to the site of action, minimizing gastrointestinal problems and adverse effects.

Methods: In the current investigation, a lecithin organogel containing lornoxicam was made by microemulsion method. For this purpose, a certain amount of pure soya lecithin was dispersed in suitable isopropyl myristate as a dispersant and emulsifier at room temperature to form the oily phase. The lecithin was completely dissolved in the combination by the next morning. Sorbic acid was then added to the mixture as a preservative, Pluronic F-127 and potassium sorbate were weighed out, and then they were mixed with cold water to create an aqueous phase, and menthol was added. On the next morning, lornoxicam, the active component, became soluble in polyethylene glycol-400 and combined with the lecithin isopropyl palmitate mixture. The oily portion was agitated using a mechanical stirrer at 400 rpm while the aqueous phase was introduced gradually.

Results: The lornoxicam organogel preparation was it was assessed for its physical appearance, organoleptic characteristics, consistency, gelation temperature, drug content, and in vitro release studies. The active ingredient content of formulation F5 was the highest at 93.33. Formulations F4 and F5 were selected for kinetic studies because they had all physical characteristics under reasonable limits, the active ingredient level was the greatest, and the active ingredient release was the fastest in eight hours.

Conclusion: The transdermal organogel formulation of lornoxicam was found to be effective for topical distribution of the drug and when administered topically, it has strong anti-inflammatory and anti-rheumatic action.

Keywords: Pluronic, lecithin, organogels, NSAIDs, topical delivery, arthritis, pain management.

« Previous Next »
Graphical Abstract

[1]
Rosenow, D.E.; Albrechtsen, M.; Stolke, D. A comparison of patient-controlled analgesia with lornoxicam versus morphine in patients undergoing lumbar disk surgery. Anesth. Analg., 1998, 86(5), 1045-1050. [International Anesthesia Research Society].
[PMID: 9585294]
[2]
Jatav, M.P.; Ramteke, S. Formulation and evaluation of lecithin organogel for treatment of arthritis. Inter. J. Sci. Wor., 2015, 3(2), 267-274.
[http://dx.doi.org/10.14419/ijsw.v3i2.5028]
[3]
Idson, B.; Lazarus, J. Semisolids. In: The theory and practice of industrial pharmacy; Vargehese Publishing House: Bombay, India, 1991; pp. 534-563.
[4]
Bhatia, A.; Singh, B.; Amarji, B.; Katare, O.P. Tamoxifen-Loaded liposomal topical formulation arrests hair growth in mice. Br J Dermatol Nurs, 2010, 163(2), 412-415.
[5]
Gupta, M.; Goyal, A.K.; Paliwal, S.R.; Paliwal, R.; Mishra, N.; Vaidya, B.; Dube, D.; Jain, S.K.; Vyas, S.P. Development and characterization of effective topical liposomal system for localized treatment of cutaneous candidiasis. J. Liposome Res., 2010, 20(4), 341-350.
[http://dx.doi.org/10.3109/08982101003596125] [PMID: 20163329]
[6]
Puglia, C.; Filosa, R.; Peduto, A.; de Caprariis, P.; Rizza, L.; Bonina, F.; Blasi, P. Evaluation of alternative strategies to optimize ketorolac transdermal delivery. AAPS PharmSciTech, 2006, 7(3), E61-E69.
[http://dx.doi.org/10.1208/pt070364] [PMID: 17025245]
[7]
Ferderber, K.; Hook, S.; Rades, T. Phosphatidyl choline-based colloidal systems for dermal and transdermal drug delivery. J. Liposome Res., 2009, 19(4), 267-277.
[http://dx.doi.org/10.3109/08982100902814006] [PMID: 19863162]
[8]
Franckum, J.; Ramsay, D.; Das, N.G.; Das, S.K. Pluronic lecithin organogel for local delivery of anti-inflammatory drugs. Int. J. Pharm. Compd., 2004, 8(2), 101-105.
[PMID: 23924620]
[9]
Shchipunov, Y.A.; Dürrschmidt, T.; Hoffmann, H. Endto end fusion of polymer like micellege in lecithin organogel under the action of an electric field. Langmuir, 2000, 16(2), 297-299.
[http://dx.doi.org/10.1021/la990810s]
[10]
Thakur, S.; Riyaz, B.; Patil, A.; Kaur, A.; Kapoor, B.; Mishra, V. Novel drug delivery systems for NSAIDs in management of rheumatoid arthritis: An overview. Biomed. Pharmacother., 2018, 106, 1011-1023.
[http://dx.doi.org/10.1016/j.biopha.2018.07.027] [PMID: 30119166]
[11]
Jhawat, V.; Gupta, S.; Saini, V. Formulation and evaluation of novel controlled release of topical pluronic lecithin organogel of mefenamic acid. Drug Deliv., 2016, 23(9), 3573-3581.
[http://dx.doi.org/10.1080/10717544.2016.1212439] [PMID: 27494650]
[12]
Shchipunov, Y.A.; Dürrschmidt, T.; Hoffmann, H. Electroheological effects in lecithin organogels with water and glycerol. J. Colloid Interface Sci., 1999, 212(2), 390-401.
[http://dx.doi.org/10.1006/jcis.1998.6046] [PMID: 10092369]
[13]
Fayez, S.M.; Gad, S.H.; Khafagy, E.S.A.; Jaleel, G.A.A.; Ghorab, M.M.; El-nahhas, S.A. Formulation and evaluation of etodolac lecithin organogel transdermal delivery systems. Int. J. Pharm. Pharm. Sci., 2015, 7(4), 325-334.
[14]
Bhatia, A.; Singh, B.; Raza, K.; Wadhwa, S.; Katare, O.P. Tamoxifen-loaded lecithin organogel (LO) for topical application: Development, optimization and characterization. Int. J. Pharm., 2013, 444(1-2), 47-59.
[http://dx.doi.org/10.1016/j.ijpharm.2013.01.029] [PMID: 23353077]
[15]
Nasseri, A.A.; Aboofazeli, R.; Zia, H.; Needham, T.E. Lecithin stabilize microemulsion. I: Phase behavior studies. Iran. J. Pharm. Res., 2003, 2, 59-61.
[16]
Willimann, H.L.; Luisi, P.L. Lecithin organogels as matrix for the transdermal transport of drugs. Biochem. Biophys. Res. Commun., 1991, 177(3), 897-900.
[http://dx.doi.org/10.1016/0006-291X(91)90622-E] [PMID: 2059217]
[17]
Bentley, M.V.L.B.; Marchetti, J.M.; Ricardo, N.; Ali-Abi, Z.; Collett, J.H. Influence of lecithin on some physical chemical properties of poloxamer gels: Rheological, microscopic and in vitro permeation studies. Int. J. Pharm., 1999, 193(1), 49-55.
[http://dx.doi.org/10.1016/S0378-5173(99)00313-0] [PMID: 10581421]
[18]
Richards, H.; Thomas, C.P.; Bowen, J.L.; Heard, C.M. In-vitro transcutaneous delivery of ketoprofen and polyunsaturated fatty acids from a pluronic lecithin organogel vehicle containing fish oil. J. Pharm. Pharmacol., 2010, 58(7), 903-908.
[http://dx.doi.org/10.1211/jpp.58.7.0004] [PMID: 16805949]
[19]
Trivedi, R.; Samrit, S.; Amgaokar, Y.; Supe, U.; Umekar, M.; Wadher, K. Formulation and evaluation of pluronic -lecithin organogel containing natural moisturizing agent for xerosis. J. Drug Deliv. Ther., 2022, 12(5), 170-174.
[http://dx.doi.org/10.22270/jddt.v12i5.5614]
[20]
Nemutlu, E.; Demircan, S.; Kir, S. Determination of lornoxicam in pharmaceutical preparations by zero and first order derivative UV spectrophotometric methods. Pharmazie, 2005, 60(6), 421-425.
[PMID: 15997830]
[21]
Couffin-Hoarau, A.C.; Motulsky, A.; Delmas, P.; Leroux, J.C. In situ-forming pharmaceutical organogels based on the self-assembly of L-alanine derivatives. Pharm. Res., 2004, 21(3), 454-457.
[http://dx.doi.org/10.1023/B:PHAM.0000019299.01265.05] [PMID: 15070096]
[22]
Soliman, S.M.; Abdel Malak, N.S.; El-Gazayerly, O.N.; Abdel Rehim, A.A. Formulation of microemulsion gel systems for transdermal delivery of celecoxib: In vitro permeation, antiinflammatory activity and skin irritation tests. Drug Discov. Ther., 2010, 4(6), 459-471.
[PMID: 22491312]
[23]
Belgamwar, V.S.; Surana, S.J.; Pandey, M.S. Topical delivery of flurbiprofen from pluronic lecithin organogel. Indian J. Pharm. Sci., 2009, 71(1), 87-90.
[http://dx.doi.org/10.4103/0250-474X.51955] [PMID: 20177469]
[24]
Nour, S.A.; Shalaby, S.H.; Afify, N.N.; Abd El-Aal, S. MMK. Formulation and evaluation of econanazole nitrate emulgels. J Drug Res Egypt, 2002, 24(1-2), 63-71.
[25]
Kasliwal, N.; Derle, D.; Negi, J.; Gohil, J. Effect of permeation enhancers on the release and permeation kinetics of meloxicam gel formulations through rat skin. Asian. J. Pharm. Sic., 2008, 3, 193-199.

Rights & Permissions Print Cite
Article Metrics
10
2
Wayfinder Image
© 2024 Bentham Science Publishers | Privacy Policy